Introduce about Pharbaco

General introduction

Central Pharmaceutical Joint Stock Company I - Pharbao, formerly known as the Central Pharmaceutical Factory No. 1, was established in 1954 up to now. With a history of 64 years of operation and development, Pharbaco Company has always affirmed to be the leading enterprise, playing a key role in the national pharmaceutical industry development strategy: ...

See more

Development process

Development process

Central Pharmaceutical Joint Stock Company I - Pharbao, formerly known as Central Pharmaceutical Factory No. 1, was established in 1954 up to now ...

See more

Leadership team

Leadership team

See more

Vision and mission

Vision and mission

maintaining its position and pioneering: Pharbaco aims to become the leading pharmaceutical manufacturer in Vietnam and the region, bringing quality Vietnamese medicine products, owned by Vietnamese people to the continent. and the world.

See more

Product line Pharbaco

Oriental medicine

1 product type

Antibiotic

2 product type

Strong heart

2 product type

Gastrointestinal - Hepatobiliary

0 product type

Itaban is not the first antibiotic of choice, but only for severe infections

Respiratory

0 product type

Musculoskeletal Joints

0 product type

Export capacityPharbaco

Pharbaco is an exporter to more than 20 countries and regions around the world, with a wide range of products, ...

See more

Nigieria

Công Gô

Moldova

Yemen

Mông Cổ

Campuchia

Myamar

Papua New Guinea

Croatia

Canada

Chile

CH Séc

Vienna

Factory and production technology

State 1

Started in 2017, expected to be completed by the end of this year (2020), including 3 lines: PFI Cephalosporin, OSD Cephalosporin, OSD Non beta-lactam 1

State 2

Started on August 15th, 2020, including 3 wires PFI Penicilllin,
PFI Carbaoenem, PFI Non beta-lactam
Phase 3: Expected to start construction at the end of 2021: include 3

State 3

Expected to start construction at the end of 2021: including 3 lines of cancer drugs + medical bio-products (this I made into a separate section to be able to continue to update when there is more specific information, because there may be stage. paragraphs 4-5)

State 3

Started in 2017, expected to be completed by the end of this year (2020), including 3 lines: PFI Cephalosporin, OSD Cephalosporin, OSD Non beta-lactam 1

State 4

Started on August 15th, 2020, including 3 wires PFI Penicilllin,
PFI Carbaoenem, PFI Non beta-lactam
Phase 3: Expected to start construction at the end of 2021: include 3

State 5

Expected to start construction at the end of 2021: including 3 lines of cancer drugs + medical bio-products (this I made into a separate section to be able to continue to update when there is more specific information, because there may be stage. paragraphs 4-5)

News

The "transformation" of Pharbaco

Oct 01, 2020 09:47:11

VietTimes – Asset size increased by times, revenue reached trillion, Central Pharmaceutical Joint Stock Company I (Pharbaco – Ticker: PBC) had a strong transformation when…

Recruitment

You want a chance to work in a leading pharmaceutical company in Vietnam. Dynamic and honest working environment. Special opportunities for promotion Annual teambuilding team building staff

See more

Partner